Use of hydroxylated amino acids for treating diabetes

Details for Australian Patent Application No. 2004282999 (hide)

Owner Innodia Inc.

Inventors Prentki, Marc; Ribes, Gerard; Bellini, Francesco; Chapal, Nicolas; Vezeau, Claude

Agent Pipers

Pub. Number AU-A-2004282999

PCT Pub. Number WO2005/039626

Priority 60/514,738 27.10.03 US

Filing date 27 October 2004

Wipo publication date 6 May 2005

International Classifications

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61K 31/198 (2006.01)

A61K 31/4439 (2006.01)

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/039626 Priority application(s): WO2005/039626

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283007-Sock

2004282998-DNA delivery with gemini cationic surfactants